Harris S. Soifer

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

Milind Javle, Sameek Roychowdhury, Robin Kate Kelley et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 425 citations

Medicine, Oncology, Cancer Pharmacology +13

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents

C.A. Stein, Jens Bo Hansen, Johnathan C. Lai et al. · Nucleic Acids Research · 2009 · 383 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann et al. · Nature Biotechnology · 2009 · 378 citations · Full text

Life Sciences, Immunology, Molecular Pharmaceutics +14

Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC

Daniela Castanotto, Kumi Sakurai, Robert Lingeman et al. · Nucleic Acids Research · 2007 · 265 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +15

L1 retrotransposition in nondividing and primary human somatic cells

Shuji Kubo, Maria del Carmen Seleme, Harris S. Soifer et al. · Proceedings of the National Academy of Sciences · 2006 · 186 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13